These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26715981)

  • 1. Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study.
    Xu Y; Xiao A; Yang J; Zhang Z; Zhang G
    Iran J Radiol; 2015 Oct; 12(4):e26009. PubMed ID: 26715981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma after TACE treatment].
    Xing G; Wang S; Li C; Zhao X; Zhou C
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):208-12. PubMed ID: 25975791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 4. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lu
    Chen J; Liu J; Xu D; Liu J; Chen X; Yang S; Yin P; Jiang Z; Mei C; Zhang X; Wang L; Zhang K; Zhou B; Shan H; Li D; Pang P
    J Control Release; 2022 Sep; 349():327-337. PubMed ID: 35787917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI.
    Kubota K; Hisa N; Nishikawa T; Fujiwara Y; Murata Y; Itoh S; Yoshida D; Yoshida S
    Abdom Imaging; 2001; 26(2):184-90. PubMed ID: 11178697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization.
    De Santis M; Alborino S; Tartoni PL; Torricelli P; Casolo A; Romagnoli R
    Eur Radiol; 1997; 7(1):10-6. PubMed ID: 9000387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
    Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
    Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dual energy spectral computed tomography in characterization of hepatocellular carcinoma: Initial experience from a tertiary liver care institute.
    Laroia ST; Bhadoria AS; Venigalla Y; Chibber GK; Bihari C; Rastogi A; Sarin SK
    Eur J Radiol Open; 2016; 3():162-71. PubMed ID: 27504474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
    Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
    World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging biomarkers on Angio-CT for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma.
    Wang H; Han Y; Chen G; Jin L
    Quant Imaging Med Surg; 2023 Jul; 13(7):4077-4088. PubMed ID: 37456312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma.
    Watanabe Y; Tokue H; Taketomi-Takahashi A; Tsushima Y
    Eur J Radiol Open; 2018; 5():171-176. PubMed ID: 30263910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ
    Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method.
    Lv P; Lin XZ; Li J; Li W; Chen K
    Radiology; 2011 Jun; 259(3):720-9. PubMed ID: 21357524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact and potential utility of non-enhanced computed tomography performed immediately after transarterial chemoembolization for hepatocellular carcinoma.
    Kim MY; Heo S; Choi S; Suh CH; Lee ES; Park HJ; Kim KW
    J Gastrointest Oncol; 2024 Jun; 15(3):1141-1152. PubMed ID: 38989419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.